Michigan Center for Skin Care Research – FDA 483, May 31, 2011
An FDA inspection of Michigan Center for Skin Care Research, a bioequivalence clinical facility, identified two observations. The firm was cited for making promotional representations on its website regarding the safety and effectiveness of investigational drugs and for offering benefits to participants. Additionally, the firm failed to ensure that an Institutional Review Board (IRB) was responsible for the initial and continuing review and approval of clinical studies, specifically regarding recruitment advertisements placed online without IRB approval.
ID · dc6e1930-cff4-489f-b118-e7594bee8e4c
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.